New User:

-or-
Username:
Password:
Forgot your password?
News Breaks
13:48 EDTCERS
theflyonthewall.com: Cerus FDA briefing docs released this mornings, says Avondale
Avondale said the FDA released briefing documents ahead of Monday's Blood Products Advisory Panel. The firm said the FDA's language is positive and increases the likelihood of a positive outcome for Cerus. Shares are Outperform rated. :theflyonthewall.com



News For CERS From The Last 14 Days
Check below for free stories on CERS the last two weeks.
There are 2 items on the Fly with pertinent information.
Sign up for a free trial to see the rest of the stories you've been missing.
February 9, 2010
08:33 EDTCERS
theflyonthewall.com: Cerus to collaborate with French national transfusion service
Cerus announced that it has entered into a collaborative agreement with France's national transfusion service, the Etablissement Français du Sang, for the development of the company's INTERCEPT Blood System for red blood cells. Terms of the agreement call for the EFS to co-invest by contributing its facilities, personnel and resources in support of clinical and commercial product development, validation, and both CE mark and French regulatory approvals. In return, EFS has certain royalty rights on future product revenue. The EFS plans to conduct the collaboration at four regional EFS establishments in France, with candidate locations including Strasbourg, Besançon, St-Etienne, Tours, Montpelier, and Marseille. :theflyonthewall.com
05:58 EDTCERS
theflyonthewall.com: Cerus announces positive results for INTERCEPT trial

Subscribe for More Information
:theflyonthewall.com